AMENDED & RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 5th, 2022 • Prime Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Employment Agreement (this “Agreement”) is made between Prime Medicine, Inc., a Delaware corporation (the “Company”), and Ann Lee, PhD (the “Executive”) to amend and restate that certain employment agreement between the Company and the Executive dated as of April 15, 2022 (the “2022 Prior Agreement”). This Agreement amends and restates the 2022 Prior Agreement and is effective upon the execution of the parties (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity Documents (each as defined below) and subject to Section 11, this Agreement supersedes in all respects all prior agreements between the Executive and the Company regarding the subject matter herein, including without limitation (i) the employment agreement between the Executive and the Company dated as of September 21, 2021 (the “Prior Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.
